Current concepts on the use of antimicrobials in cats

Veterinary Journal

Volumn 180, Issue 3, 2009, Pages 304-316

  Albarellos, G A ^a   Landoni, M F ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Antibiotics; Antimicrobials; Cats; Chemotherapy; Feline; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BENZATHINE PENICILLIN; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; CLOXACILLIN; DICLOXACILLIN; MACROLIDE; MONOBACTAM DERIVATIVE; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G POTASSIUM; PENICILLIN G SODIUM; PENICILLIN V; PIPERACILLIN; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TETRACYCLINE DERIVATIVE; TICARCILLIN; UNINDEXED DRUG;

BACTERIAL INFECTION; CAT DISEASE; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENTIATION; DRUG TISSUE LEVEL; GASTROINTESTINAL TOXICITY; OTOTOXICITY; REVIEW; SINGLE DRUG DOSE; TREATMENT INDICATION; VOMITING;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CAT DISEASES; CATS;

FELIDAE;

EID: 61849085829     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.01.001     Document Type: Review

References (97)

1. Albarellos G.A., Kreil V.E., and Landoni M.F. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 155-162
2. Albarellos G.A., Montoya L., and Landoni M.F. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats. The Veterinary Journal 170 (2005) 222-229
3. Albarellos G.A., Ambros L.A., and Landoni M.F. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 363-369
4. Albarellos G., Kreil V., Montoya L., Ambros L., Velo M., and Landoni M. PK/PD of cefazolin after intravenous administration to cats. Journal of Veterinary Pharmacology and Therapeutics 29 Suppl. 1 (2006) 252
5. Albarellos G., Montoya L., Kreil V., Ambros L., Velo M., and Landoni M. PK/PD of cephalothin after intravenous administration to cats. Journal of Veterinary Pharmacology and Therapeutics 29 Suppl. 1 (2006) 272-273
6. Albarellos G.A., Kreil V.E., and Landoni M.F. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats. Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 345-352
7. Albarellos G.A., Ambros L.A., and Landoni M.F. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats. The Veterinary Journal (2007) 10.1016/j.tvjl.2007.06.026
8. Aronson L.R., and Drobatz R. Acetaminophen toxicosis in 17 cats. Journal of Veterinary Emergency and Critical Care 6 (1996) 65-69
9. Barr S.C., Jamrosz G.F., Hornbuckle W.E., Bowman D.D., and Fayer R. Use of paromomycin for treatment of cryptosporidiosis in a cat. Journal of the American Veterinary Medical Association 205 (1994) 1742-1743
10. Beatty J.A., Swift N., Foster D.J., and Barrs V.R.D. Suspected clindamycin-associated oesophageal injury in cats: five cases. Journal of Feline Medicine and Surgery 8 (2006) 412-419
11. Boothe D.M. The practical aspects of treating bacterial infections in cats. Veterinary Medicine 84 (1989) 884-904
12. Boothe D.M. Drug therapy in cats: mechanisms and avoidance of adverse drug reactions. Journal of the American Veterinary Medical Association 196 (1990) 1297-1305
13. Boothe D.M. Drug therapy in cats: a systems approach. Journal of the American Veterinary Medical Association 196 (1990) 1502-1511
14. Boothe D.M. Drug therapy in cats: a therapeutic category approach. Journal of the American Veterinary Medical Association 196 (1990) 1659-1669
15. Boothe D.M., Brown S.A., Fate G.D., Pierce P.A., Hanson B.J., Al-Adhami M., Boothe H.W., Howe L.B., and Nguyen J. Plasma disposition of clindamycin microbiological activity in cats after single oral doses of clindamycin hydrochloride as either capsules or aqueous solution. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 491-494
16. Bouloy R.P., Lappin M.R., Holland C.H., Thrall M.A., Baker D., and O'Neil S. Clinical ehrlichiosis in a cat. Journal of the American Veterinary Medical Association 204 (1994) 1475-1478
17. Brown S.A. Treatment of Gram-negative infections. Veterinary Clinics of North America: Small Animal Practice 18 (1988) 1141-1165
18. Brown S.A., Dieringer T.M., Hunter R.P., and Zaya M.J. Oral clindamycin disposition after single and multiple doses in normal cats. Journal of Veterinary Pharmacology and Therapeutics 12 (1989) 209-216
19. Brown S.A., Zaya M.J., Dieringer T.M., Hunter R.P., Nappier J.L., Hoffman G.A., Hornish R.E., and Yein F.S. Tissue concentrations of clindamycin after multiple oral doses in normal cats. Journal of Veterinary Pharmacology and Therapeutics 13 (1990) 270-277
20. Bushby S.R.M. Sulfonamide and trimethoprim combinations. Journal of the American Veterinary Medical Association 176 (1980) 1049-1053
21. Campbell K.L. Sulphonamides: updates on use in veterinary medicine. Veterinary Dermatology 10 (1999) 205-215
22. Cester C.C., Schneider M., and Toutain P.L. Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Medicine Vétérinaire 147 (1996) 703-716
23. Chatfield R.C., Gingerich D.A., Rourke J.E., and Strom P.W. Cefadroxil: a new orally effective cephalosporin antibiotic. Veterinary Medicine 79 (1984) 339-346
24. Chicoine A.L., Cox W.R., Weich E.I., Huang L., Wong J., and Dowling P.M. Pharmacokinetics of a novel amoxicillin paste formulation in cats. Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 172-174
25. Christensen E.F., Reiffenstein J.C., and Madissoo H. Comparative ototoxicity of amikacin and gentamicin in cats. Antimicrobial Agents and Chemotherapy 12 (1977) 178-184
26. Clark C.H. Toxicity of aminoglycoside antibiotics. Modern Veterinary Practice 58 (1977) 594-598
27. Coulet M., Morello C., Cox P., and Lohuis J. Pharmacokinetics of ibafloxacin in healthy cats. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 37-44
28. Crosse R., and Burt D.G. Antibiotic concentration in the serum of dogs and cats following a single oral dose of cephalexin. The Veterinary Record 115 (1984) 106-107
29. Davidson M.G., Lappin M.R., Rottman J.R., Tompkins M.B., English R.V., Bruce A.T., and Jayawickrama J. Antimicrobial Agents and Chemotherapy 40 (1996) 1352-1359
30. Dimitrova D.J. Pharmacokinetics of dicloxacillin sodium following intravenous and intramuscular administration to domestic cats. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 405-407
31. Dossin O., Gruet P., and Thomas E. Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections. Journal of Small Animal Practice 39 (1998) 286-289
32. Dow S.W. Management of anaerobic infections. Veterinary Clinics of North America: Small Animal Practice 18 (1988) 1167-1182
33. Dowers K.L., Olver C., Radecki S.V., and Lappin M.R. Use of enrofloxacin for treatment of large-form Haemobartonella felis in experimentally infected cats. Journal of the American Veterinary Medical Association 221 (2002) 250-253
34. Farca A.M., Cavana P., Robino P., and Nebbia P. In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals. Schweizer Archiv für Tierheilkunde 149 (2007) 265-271
35. Ford M.M., Dubielzig R.R., Giuliano E.A., Moore C.P., and Narfström K.L. Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats. American Journal of Veterinary Research 68 (2007) 190-202
36. Forsyth S.F., Ilkiw J.E., and Hildebrand S.V. Effect of gentamicin administration on the neuromuscular blockade induced by atracurium in cats. American Journal of Veterinary Research 51 (1990) 1675-1678
37. Gelatt K.N., van der Woerdt A., Ketring K.L., Andrew S.E., Brooks D.E., Biros D.J., Denis H.M., and Cutler T.J. Enrofloxacin-associated retinal degeneration in cats. Veterinary Ophthalmology 4 (2001) 99-106
38. Gerhardt N., Schulz B.S., Werckenthin C., and Hartmann K. Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. The Veterinary Record 159 (2006) 591-594
39. German A.J., Cannon M.J., Dye C., Booth M.J., Pearson G.R., Reay C.A., and Gruffydd-Jones T.J. Oesophageal strictures in cats associated with doxycicline therapy. Journal of Feline Medicine and Surgery 7 (2005) 33-41
40. Goldstein R., Lavy E., Shem-Tov M., Glickman A., Bark H., and Ziv G. Pharmacokinetics of ampicillin administered intravenously and intraosseously to kittens. Research in Veterinary Science 59 (1995) 186-187
41. Gookin J.L., Riviere J.E., Gilger B.C., and Papich M.G. Acute renal failure in four cats treated with paromomycin. Journal of the Veterinary Medical Association 215 (1999) 1821-1823
42. Grahn B.H., Storey E.S., and Cullen C.L. Diagnostic ophthalmology. Canadian Veterinary Journal 43 (2002) 137-138
43. Harari J., and Lincoln J. Pharmacologic features of clindamycin in dogs and cats. Journal of the American Veterinary Medical Association 195 (1989) 124-125
44. Harvey R.G., and Hunter P.A. The properties and use of penicillins in the veterinary field, with special reference to skin infections in dogs and cats. Veterinary Dermatology 10 (1999) 177-186
45. Heinen, E., 2000. Comparative pharmacokinetics of enrofloxacin, marbofloxacin, and orbifloxacin in cats after single oral administration. In: Proceedings of the eighth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Israel, Abstract L11.
46. Hunter R.P., Lynch M.J., Ericson J.F., Millas W.J., Fletcher A.M., Ryan N.I., and Olson J.A. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 38-46
47. Indiveri M.C., and Hirsh D.C. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole. Journal of the American Veterinary Medical Association 188 (1986) 46-48
48. Jacobson E.R., Groff J.M., Gronwall R.R., Moreland A.F., and Chung M. Serum concentrations of gentamicin in cats. American Journal of Veterinary Research 46 (1985) 1356-1358
49. Jernigan A.D., Wilson R.C., Hatch R.C., and Kemp D.T. Pharmacokinetics of gentamicin after intravenous, intramuscular, and subcutaneous administration in cats. American Journal of Veterinary Research 49 (1988) 32-35
50. Jernigan A.D., Wilson R.C., and Hatch R.C. Pharmacokinetics of amikacin in cats. American Journal of Veterinary Research 49 (1988) 355-358
51. Jernigan A.D., Hatch R.C., Wilson R.C., Brown J., and Tuler S.M. Pharmacokinetics of gentamicin in cats given Escherichia coli endotoxin. American Journal of Veterinary Research 49 (1988) 603-607
52. Jernigan A.D., Hatch R.C., and Wilson R.C. Pharmacokinetics of tobramicin in cats. American Journal of Veterinary Research 49 (1988) 608-612
53. Jernigan A.D., Hatch R.C., Wilson R.C., Brown J., and Crowell W.A. Pathologic changes and tissue gentamicin concentrations after intravenous gentamicin administration in clinically normal and endotoxemic cats. American Journal of Veterinary Research 49 (1988) 613-617
54. Jernigan A.D., Hatch R.C., Brown J., and Crowell W.A. Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days. Canadian Journal of Veterinary Research 52 (1988) 177-180
55. Jones R.L., Godinho K.S., and Palmer G.H. Clinical observations on the use of oral amoxycillin/clavulanate in the treatment of gingivitis in dogs and cats and anal sacculitis in dogs. British Veterinary Journal 150 (1994) 385-388
56. Jordan D.G. Azithromycin. Compendium on Continuing Education for the Practising Veterinarian 23 (2001) 242-269
57. Kaufman A.C., and Greene C.E. Increased alanine transaminase activity associated with tetracycline administration in a cat. Journal of the American Veterinary Medical Association 202 (1993) 628-630
58. Kordick D.L., Papich M.G., and Breitschwerdt E.B. Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infections in cats. Antimicrobial Agents and Chemotherapy 41 (1997) 2448-2455
59. Landoni M.F., Albarellos G.A., Montoya L., and Hallu R.E. Pharmacokinetics of intravenous and two intramuscular formulations of amoxicillin in cats. Journal of Veterinary Pharmacology and Therapeutics 26 Suppl. 1 (2003) 135-136
60. Mason K.V., and Day M.J. A pemphigus foliaceus-like eruption associated with the use of ampicillin in a cat. Australian Veterinary Journal 64 (1987) 223-224
61. McElroy D., Ravis W.R., and Clark C.H. Pharmacokinetics of cefotaxime in the domestic cat. American Journal of Veterinary Research 47 (1986) 86-88
62. Mealey K.L., and Boothe D.M. Nephrotoxicosis associated with topical administration of gentamicin in a cat. Journal of the American Veterinary Medical Association 204 (1994) 1919-1921
63. Mealey K.L. Penicillins and β-lactamase inhibitor combinations. Journal of the American Veterinary Medical Association 218 (2001) 1893-1896
64. Mercer H.D., Garg R.C., Powers J.D., and Powers T.E. Bioavailability and pharmacokinetics of several dosage forms of ampicillin in the cat. American Journal of Veterinary Research 38 (1977) 1353-1359
65. Meunier D., Acar J.F., Martel J.L., Kroemer S., and Valle M. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. International Journal of Antimicrobial Agents 24 (2004) 592-598
66. Noli C., Koeman J.P., and Willemse T. A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats. The Veterinary Quarterly 17 (1995) 123-128
67. Noli C., and Boothe D. Macrolides and lincosamides. Veterinary Dermatology 10 (1999) 217-223
68. Olson E.J., Morales S.C., McVey A.S., and Hayden D.W. Putative metronidazole neurotoxicosis in a cat. Veterinary Pathology 42 (2005) 665-669
69. Papich M.G. Therapy of Gram-positive bacterial infections. Veterinary Clinics of North America: Small Animal Practice 18 (1988) 1267-1285
70. Papich M.G. Antibacterial drug therapy. Focus on new drugs. Veterinary Clinics of North America: Small Animal Practice 28 (1998) 215-231
71. Papich M.G., and Riviere J.E. Chloramphenicol and derivatives, macrolides, lincosamides, and miscellaneous antimicrobials. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. eighth ed. (2001), Iowa State University Press, Ames, Iowa, USA 868-897
72. Papich M.G., and Riviere J.E. Fluoroquinolone antimicrobial drugs. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. eighth ed. (2001), Iowa State University Press, Ames, Iowa, USA 898-917
73. Richez P., Monluis J.D., Dellac B., and Daube G. Validation of a therapeutic regimen for enrofloxacin in cats on the basis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics 20 Suppl. 1 (1997) 152-153
74. Riond J.L., Vaden S.L., and Riviere J.E. Comparative pharmacokinetics of doxycycline in cats and dogs. Journal of Veterinary Pharmacology and Therapeutics 13 (1990) 415-424
75. Riviere J.E., and Spoo J.W. Tetracycline antibiotics. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. eighth ed. (2001), Iowa State University Press, Ames, Iowa, USA 828-840
76. Riviere J.E., and Spoo J.W. Aminoglycoside antibiotics. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. eighth ed. (2001), Iowa State University Press, Ames, Iowa, USA 841-867
77. Roy J., Messier S., Labrecque O., and Cox W.R. Clinical and in vitro efficacy of amoxicillin against bacteria associated with feline skin wounds and abscesses. Canadian Veterinary Journal 48 (2007) 607-611
78. Seguin M.A., Papich M.G., Sigle K.J., Gibson N.M., and Levy J.K. Pharmacokinetics of enrofloxacin in neonatal kittens. American Journal of Veterinary Research 65 (2004) 350-356
79. Senior D.F., Gaskin J.M., Buergelt C.D., Franks P.P., and Keefe T.J. Amoxicillin and clavulanic acid combination in the treatment of experimentally induced bacterial cystitis in cats. Research in Veterinary Science 39 (1985) 42-46
80. Shille V.M., Brown M.P., Gronwall R., and Hock H. Amikacin sulfate in the cat: serum, urine and uterine tissue concentrations. Theriogenology 23 (1985) 829-839
81. Silley P., Rudd A.P., Symington W.M., and Tait A.J. Pharmacokinetics of cephalexin in dogs and cats after oral, subcutaneous and intramuscular administration. The Veterinary Record 122 (1988) 15-17
82. Spoo J.W., and Riviere J.E. Sulfonamides. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. third ed. (2001), Iowa State University Press, Ames, Iowa, USA 796-817
83. Stegemann M.R., Sherington J., Coati N., Brown S.A., and Blanchflower S. Pharmacokinetics of cefovecin in cats. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 513-524
84. Studdert V.P., and Hughes K.L. Treatment of opportunistic mycobacterial infections with enrofloxacin in cats. Journal of the American Veterinary Medical Association 201 (1992) 1388-1390
85. Teske R.H., and Mercer H.D. Subchronic effects of chloramphenicol on the hemopoietic system of cats. Canadian Veterinary Journal 17 (1976) 19-23
86. Thornton J.R., and Martin P.J. Pharmacokinetics of cephalexin in cats after oral administration of the antibiotic in tablet and paste preparations. Australian Veterinary Journal 75 (1997) 439-440
87. Vaden S.L., and Riviere J.E. Penicillins and related β-lactam antibiotics. In: Adams H.R. (Ed). Veterinary Pharmacology and Therapeutics. third ed. (2001), Iowa State University Press, Ames, Iowa, USA 818-827
88. Wackowiez G., Richard J., and Fabreguettes G. Pharmacokinetics of cefalexin in plasma and urine after single intravenous and oral (tablets) administration in cats. Journal of Veterinary Pharmacology and Therapeutics 20 Suppl. 1 (1997) 64-65
89. Watson A.D.J., and Middleton D.J. Chloramphenicol toxicosis in cats. American Journal of Veterinary Research 39 (1978) 1199-1203
90. Watson A.D.J. Effect of ingesta on systemic availability of chloramphenicol from two oral preparations in cats. Journal of Veterinary Pharmacology and Therapeutics 2 (1979) 117-121
91. Watson A.D.J. Further observations on chloramphenicol toxicosis in cats. American Journal of Veterinary Research 41 (1980) 293-294
92. Watson A.D.J. Chloramphenicol 2. Clinical pharmacology in dogs and cats. Australian Veterinary Journal 68 (1991) 2-5
93. Westfall D.S., Jensen W.A., Reagan W.J., Radecki S.V., and Lappin M.R. Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin. American Journal of Veterinary Research 62 (2001) 687-691
94. White S.D. Systemic treatment of bacterial skin infections of dogs and cats. Veterinary Dermatology 7 (1996) 133-143
95. Wiebe V., and Hamilton P. Fluoroquinolone-induced retinal degeneration in cats. Journal of the American Veterinary Medical Association 221 (2002) 1568-1571
96. Wilke J.R. Idiosyncrasies of drug metabolism in cats. Veterinary Clinics of North America: Small Animal Practice 14 (1984) 1345-1354
97. Wright L.C., Horton C.R., Jernigan A.D., Wilson R.C., and Clark C.H. Pharmacokinetics of gentamicin after intravenous and subcutaneous injection in obese cats. Journal of Veterinary Pharmacology and Therapeutics 14 (1991) 96-100